Bridion 200 MG/2 ML vial 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXSZ6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,724
Award facts
- Contract value 100% obligated
- $12,723.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,723.66 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on January 7, 2026, with completion expected by January 8, 2026. This firm fixed-price, competitively awarded delivery order represents a routine pharmaceutical procurement with no set-aside designation. Bridion (sugammadex) is a neuromuscular blocking agent reversal medication used in surgical and anesthesia settings. The award utilizes AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, operates as a subsidiary of parent company Cencora, Inc. The company functions as a critical vendor within the federal medical supply chain, regularly fulfilling pharmaceutical procurement needs for military and veteran healthcare systems through the DLA. This delivery order reflects the company's established capability to meet federal procurement requirements across multiple therapeutic domains, from specialty medications to generic drugs and medical devices. The work will be performed at AmerisourceBergen's Conshohocken facility, supporting the Defense Logistics Agency's mission to maintain pharmaceutical inventory for the Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FXSZ6?
SPE2DR26FXSZ6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FXSZ6 worth?
The government has obligated $12,724 on SPE2DR26FXSZ6.
Is contract SPE2DR26FXSZ6 an order under another contract?
Yes. SPE2DR26FXSZ6 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXSZ6 competed?
The extent of competition for SPE2DR26FXSZ6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award